CDMOP Stock Price, Chart, Stats & News

Avid Bioservices, Inc.
Save
–
Market cap
–
Current P/E
–
Forward P/E
CDMOP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 5.23% |
Operating margin | -13.35% |
Pretax margin | -19.25% |
Net margin | -100.60% |
Effective tax rate | -422.72% |
ROA | -41.82% |
ROE | -112.44% |
D/E | 3.41x |
Interest coverage ratio | -4.31x |
CDMOP valuation
P/E | – |
P/S | 5.71x |
P/B | 12.96x |
P/CF | 72.07x |
P/FCF | -38.31x |
P/OCF | 72.07x |
PEG | 1.06x |
EV multiple | -54.80x |
About
Avid Bioservices, Inc. functions as a contract development and manufacturing organization (CDMO) with a core specialization in biopharmaceutical drug substances cultivated through mammalian cell culture. The company excels in the production of crucial biologics, including monoclonal antibodies and recombinant proteins. Its extensive range of services covers both process development—encompassing upstream and downstream optimization, as well as the creation, testing, and characterization of analytical methods—and full current Good Manufacturing Practices (CGMP) compliant clinical and commercial manufacturing.
Similar securities
Based on sector and market capitalization
Report issue











